集中注射器服务、COVID-19 疫苗接种和传染病检测:巴尔的摩的经验。

IF 8.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Omeid Heidari, Diane Meyer, Kelly Lowensen, Amita Patil, Katie J O'Conor, Jessica LaRicci, Derrick Hunt, Adam P Bocek, Victoria Cargill, Jason E Farley
{"title":"集中注射器服务、COVID-19 疫苗接种和传染病检测:巴尔的摩的经验。","authors":"Omeid Heidari, Diane Meyer, Kelly Lowensen, Amita Patil, Katie J O'Conor, Jessica LaRicci, Derrick Hunt, Adam P Bocek, Victoria Cargill, Jason E Farley","doi":"10.1377/hlthaff.2024.00032","DOIUrl":null,"url":null,"abstract":"<p><p>People who inject drugs face many challenges that contribute to poor health outcomes, including drug overdose, HIV, and hepatitis C infections. These conditions require high-quality prevention and treatment services. Syringe services programs are evidence-based harm reduction programs, and they have established track records with people who inject drugs, earning them deep trust within this population. In Baltimore, Maryland, although many syringe support services were limited during the COVID-19 pandemic, the health department's syringe services programs remained operational, allowing for the continuation of harm reduction services, including naloxone distribution. This evaluation describes a collaborative effort to colocate infectious disease testing and COVID-19 vaccination with a syringe services program. Our evaluation demonstrated that colocation of important services with trusted community partners can facilitate engagement and is essential for service uptake. Maintaining adequate and consistent funding for these services is central to program success. Colocation of other services within syringe services programs, such as medications for opioid use disorder, wound care, and infectious disease treatment, would further expand health care access for people who inject drugs.</p>","PeriodicalId":50411,"journal":{"name":"Health Affairs","volume":"43 6","pages":"883-891"},"PeriodicalIF":8.6000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567152/pdf/","citationCount":"0","resultStr":"{\"title\":\"Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.\",\"authors\":\"Omeid Heidari, Diane Meyer, Kelly Lowensen, Amita Patil, Katie J O'Conor, Jessica LaRicci, Derrick Hunt, Adam P Bocek, Victoria Cargill, Jason E Farley\",\"doi\":\"10.1377/hlthaff.2024.00032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>People who inject drugs face many challenges that contribute to poor health outcomes, including drug overdose, HIV, and hepatitis C infections. These conditions require high-quality prevention and treatment services. Syringe services programs are evidence-based harm reduction programs, and they have established track records with people who inject drugs, earning them deep trust within this population. In Baltimore, Maryland, although many syringe support services were limited during the COVID-19 pandemic, the health department's syringe services programs remained operational, allowing for the continuation of harm reduction services, including naloxone distribution. This evaluation describes a collaborative effort to colocate infectious disease testing and COVID-19 vaccination with a syringe services program. Our evaluation demonstrated that colocation of important services with trusted community partners can facilitate engagement and is essential for service uptake. Maintaining adequate and consistent funding for these services is central to program success. Colocation of other services within syringe services programs, such as medications for opioid use disorder, wound care, and infectious disease treatment, would further expand health care access for people who inject drugs.</p>\",\"PeriodicalId\":50411,\"journal\":{\"name\":\"Health Affairs\",\"volume\":\"43 6\",\"pages\":\"883-891\"},\"PeriodicalIF\":8.6000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567152/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Affairs\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1377/hlthaff.2024.00032\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Affairs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1377/hlthaff.2024.00032","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

注射吸毒者面临着许多挑战,这些挑战导致了不良的健康后果,包括吸毒过量、艾滋病毒和丙型肝炎感染。这些情况需要高质量的预防和治疗服务。注射器服务计划是以证据为基础的减低伤害计划,它们在注射吸毒者中建立了良好的记录,在这一人群中赢得了深厚的信任。在马里兰州巴尔的摩市,尽管在 COVID-19 大流行期间许多注射器支持服务受到限制,但卫生部门的注射器服务计划仍在运行,从而使包括纳洛酮分发在内的减低危害服务得以继续。本评估介绍了将传染病检测和 COVID-19 疫苗接种与注射器服务计划同地进行的合作努力。我们的评估表明,将重要的服务与值得信赖的社区合作伙伴集中在一起可以促进参与,对服务的吸收至关重要。为这些服务保持充足、稳定的资金是计划成功的关键。在注射器服务计划内提供其他服务,如治疗阿片类药物使用障碍的药物、伤口护理和传染病治疗,将进一步扩大注射吸毒者获得医疗保健的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.

People who inject drugs face many challenges that contribute to poor health outcomes, including drug overdose, HIV, and hepatitis C infections. These conditions require high-quality prevention and treatment services. Syringe services programs are evidence-based harm reduction programs, and they have established track records with people who inject drugs, earning them deep trust within this population. In Baltimore, Maryland, although many syringe support services were limited during the COVID-19 pandemic, the health department's syringe services programs remained operational, allowing for the continuation of harm reduction services, including naloxone distribution. This evaluation describes a collaborative effort to colocate infectious disease testing and COVID-19 vaccination with a syringe services program. Our evaluation demonstrated that colocation of important services with trusted community partners can facilitate engagement and is essential for service uptake. Maintaining adequate and consistent funding for these services is central to program success. Colocation of other services within syringe services programs, such as medications for opioid use disorder, wound care, and infectious disease treatment, would further expand health care access for people who inject drugs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Affairs
Health Affairs 医学-卫生保健
CiteScore
15.00
自引率
2.10%
发文量
246
审稿时长
3-6 weeks
期刊介绍: Health Affairs is a prestigious journal that aims to thoroughly examine significant health policy matters both domestically and globally. Our publication is committed to addressing issues that are relevant to both the private and public sectors. We are enthusiastic about inviting private and public decision-makers to contribute their innovative ideas in a publishable format. Health Affairs seeks to incorporate various perspectives from industry, labor, government, and academia, ensuring that our readers benefit from the diverse viewpoints within the healthcare field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信